Antidiabetic Activity ofGnidia glaucaandDioscorea bulbifera: Potent Amylase and Glucosidase Inhibitors

Author:

Ghosh Sougata1,Ahire Mehul1,Patil Sumersing1,Jabgunde Amit2,Bhat Dusane Meenakshi1,Joshi Bimba N.3,Pardesi Karishma4,Jachak Sanjay5,Dhavale Dilip D.2,Chopade Balu A.1

Affiliation:

1. Institute of Bioinformatics and Biotechnology, University of Pune, Pune 411007, India

2. Garware Research Centre, Department of Chemistry, University of Pune, Pune 411007, India

3. Animal Sciences Division, Agharkar Research Institute, Pune 411004, India

4. Department of Microbiology, University of Pune, Pune 411007, India

5. Department of Natural Products, National Institute of Pharmaceutical Education and Research, Mohali 160062, India

Abstract

Diabetes is a metabolic disorder affecting about 220 million people worldwide. One of the most critical complications of diabetes is post-prandial hyper-glycemia (PPHG). Glucosidase inhibitor andα-amylase inhibitors are class of compounds that help in managing PPHG. Low-cost herbal treatment is recommended due to their lesser side effect for treatment of diabetes. Two plants with significant traditional therapeutic potential, namely,Gnidia glaucaandDioscorea bulbifera, were tested for their efficiency to inhibitα-amylase andα-glucosidase. Stem, leaf, and flower ofG. glaucaand bulb ofD. bulbiferawere sequentially extracted with petroleum ether, ethyl acetate, and methanol as well as separately with 70% ethanol. Petroleum ether extract of flower ofG. glaucawas found to inhibitα-amylase significantly (78.56%). Extracts were further tested against crude murine pancreatic, small intestinal, and liver glucosidase enzyme which revealed excellent inhibitory properties.α-glucosidase inhibition provided a strongin vitroevidence for confirmation of bothG. glaucaandD. bulbiferaas excellent antidiabetic remedy. This is the first report of its kind that provides a strong biochemical basis for management of type II diabetes usingG. glaucaandD. bulbifera. These results provide intense rationale for furtherin vivoand clinical study.

Publisher

Hindawi Limited

Subject

Complementary and alternative medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3